{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:32:09Z","timestamp":1793637129405,"version":"4.5.1"},"reference-count":97,"publisher":"American Medical Association (AMA)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,12,28]]},"DOI":"10.1001\/jama.2021.21392","type":"journal-article","created":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T11:06:11Z","timestamp":1640689571000},"page":"2507","source":"Crossref","is-referenced-by-count":329,"title":["Contraception Selection, Effectiveness, and Adverse Effects"],"prefix":"10.1001","volume":"326","author":[{"given":"Stephanie","family":"Teal","sequence":"first","affiliation":[{"name":"Department of OB\/GYN, University Hospitals Medical Center and Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Edelman","sequence":"additional","affiliation":[{"name":"Department of OB\/GYN, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"62","key":"jrv210017r1","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 1982-2010.","author":"Daniels","year":"2013","journal-title":"Natl Health Stat Report"},{"issue":"2","key":"jrv210017r2","first-page":"83","article-title":"Use of contraception among reproductive-aged women in the United States, 2014 and 2016.","volume":"1","author":"Kavanaugh","year":"2020","journal-title":"F S Rep"},{"issue":"1","key":"jrv210017r5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.contraception.2018.08.014","article-title":"Beyond intent: exploring the association of contraceptive choice with questions about Pregnancy Attitudes, Timing and How important is pregnancy prevention (PATH) questions.","volume":"99","author":"Geist","year":"2019","journal-title":"Contraception"},{"issue":"1","key":"jrv210017r6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.contraception.2013.05.003","article-title":"One Key Question: preventive reproductive health is part of high quality primary care.","volume":"88","author":"Bellanca","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"jrv210017r7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.contraception.2011.04.009","article-title":"Ovulation inhibition doses of progestins: a systematic review of the available literature and of marketed preparations worldwide.","volume":"84","author":"Endrikat","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"jrv210017r8","first-page":"687","article-title":"Synthesis and release of gonadotropins: effect of an oral contraceptive.","volume":"62","author":"Dericks-Tan","year":"1983","journal-title":"Obstet Gynecol"},{"issue":"5","key":"jrv210017r9","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/humrep\/13.5.1218","article-title":"Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.","volume":"13","author":"Critchley","year":"1998","journal-title":"Hum Reprod"},{"issue":"11","key":"jrv210017r10","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/humrep\/13.11.2991","article-title":"The effect of ovarian steroids on epithelial ciliary beat frequency in the human fallopian tube.","volume":"13","author":"Mahmood","year":"1998","journal-title":"Hum Reprod"},{"issue":"1","key":"jrv210017r11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0015-0282(16)40875-7","article-title":"In vitro action of progestogens on sperm migration in human cervical mucus.","volume":"26","author":"Kesser\u00fc","year":"1975","journal-title":"Fertil Steril"},{"issue":"1","key":"jrv210017r12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1363\/psrh.2017.49.issue-1","article-title":"Contraceptive failure in the United States: estimates from the 2006-2010 National Survey of Family Growth.","volume":"49","author":"Sundaram","year":"2017","journal-title":"Perspect Sex Reprod Health"},{"issue":"21","key":"jrv210017r13","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception.","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv210017r14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.contraception.2015.12.007","article-title":"Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake.","volume":"93","author":"Duijkers","year":"2016","journal-title":"Contraception"},{"issue":"11","key":"jrv210017r15","article-title":"Progestin-only pills for contraception.","author":"Grimes","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"jrv210017r16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"4","key":"jrv210017r17","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S0015-0282(16)37443-X","article-title":"Analysis of bleeding patterns and resumption of fertility following discontinuation of a long acting injectable contraceptive.","volume":"21","author":"Gardner","year":"1970","journal-title":"Fertil Steril"},{"issue":"2","key":"jrv210017r19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/13625187.2018.1449825","article-title":"Bleeding patterns for the Liletta levonorgestrel 52?mg intrauterine system.","volume":"23","author":"Schreiber","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"11","key":"jrv210017r20","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/humrep\/dew222","article-title":"Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.","volume":"31","author":"Ali","year":"2016","journal-title":"Hum Reprod"},{"key":"jrv210017r21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns.","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"2","key":"jrv210017r22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0010-7824(88)90038-8","article-title":"Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception.","volume":"38","author":"Belsey","year":"1988","journal-title":"Contraception"},{"issue":"5599","key":"jrv210017r23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/bmj.2.5599.199","article-title":"Investigation of relation between use of oral contraceptives and thromboembolic disease.","volume":"2","author":"Vessey","year":"1968","journal-title":"Br Med J"},{"issue":"5","key":"jrv210017r24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.contraception.2006.12.018","article-title":"Range of published estimates of venous thromboembolism incidence in young women.","volume":"75","author":"Heinemann","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"jrv210017r25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM199607043350102","article-title":"Stroke in users of low-dose oral contraceptives.","volume":"335","author":"Petitti","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"jrv210017r26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/humupd\/dmt028","article-title":"Venous thromboembolism in women: a specific reproductive health risk.","volume":"19","author":"ESHRE Capri Workshop Group","year":"2013","journal-title":"Hum Reprod Update"},{"issue":"5","key":"jrv210017r27","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","article-title":"The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.","volume":"75","author":"Dinger","year":"2007","journal-title":"Contraception"},{"key":"jrv210017r28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2288-9-77","article-title":"International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study).","volume":"9","author":"Dinger","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"jrv210017r29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period: a systematic review.","volume":"117","author":"Jackson","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"6","key":"jrv210017r30","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.contraception.2016.04.014","article-title":"Progestin-only contraception and thromboembolism: a systematic review.","volume":"94","author":"Tepper","year":"2016","journal-title":"Contraception"},{"key":"jrv210017r31","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"issue":"2","key":"jrv210017r33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.contraception.2005.03.010","article-title":"Fertility awareness-based methods for contraception: systematic review of randomized controlled trials.","volume":"72","author":"Grimes","year":"2005","journal-title":"Contraception"},{"issue":"6, pt 2","key":"jrv210017r34","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/S0002-9378(11)90581-X","article-title":"Further analysis of contraceptive failure of the ovulation method.","volume":"165","author":"Trussell","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"jrv210017r35","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.contraception.2007.01.020","article-title":"Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.","volume":"75","author":"Ortiz","year":"2007","journal-title":"Contraception"},{"issue":"4","key":"jrv210017r36","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/0010-7824(90)90046-X","article-title":"Long-term contraception with the levonorgestrel 20 mcg\/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.","volume":"42","author":"Sivin","year":"1990","journal-title":"Contraception"},{"issue":"8","key":"jrv210017r37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1056\/NEJMoa010438","article-title":"Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women.","volume":"345","author":"Hubacher","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"jrv210017r38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.contraception.2015.06.012","article-title":"Risk-based screening for Chlamydia trachomatis and Neisseria gonorrhoeae prior to intrauterine device insertion.","volume":"92","author":"Grentzer","year":"2015","journal-title":"Contraception"},{"issue":"6","key":"jrv210017r39","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/AOG.0b013e318273364c","article-title":"Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.","volume":"120","author":"Sufrin","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"5","key":"jrv210017r40","doi-asserted-by":"publisher","first-page":"599.e1","DOI":"10.1016\/j.ajog.2016.05.017","article-title":"A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.","volume":"215","author":"Turok","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"jrv210017r41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? a systematic review.","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"jrv210017r43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa2022141","article-title":"Levonorgestrel vs copper intrauterine devices for emergency contraception.","volume":"384","author":"Turok","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"jrv210017r44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.contraception.2016.01.009","article-title":"Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.","volume":"93","author":"Turok","year":"2016","journal-title":"Contraception"},{"issue":"9348","key":"jrv210017r45","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(02)11767-3","article-title":"Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.","volume":"360","author":"von Hertzen","year":"2002","journal-title":"Lancet"},{"issue":"9714","key":"jrv210017r46","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"jrv210017r47","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.contraception.2013.05.010","article-title":"Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens.","volume":"88","author":"Brache","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"jrv210017r48","article-title":"Advance provision of emergency contraception for pregnancy prevention (full review).","author":"Polis","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv210017r49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/OGX.0b013e318285bc06","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? data from randomized trials of ulipristal acetate and levonorgestrel.","volume":"68","author":"Glasier","year":"2013","journal-title":"Obstet Gynecol Surv"},{"issue":"3","key":"jrv210017r50","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/AOG.0b013e318209dc25","article-title":"Pericoital oral contraception with levonorgestrel: a systematic review.","volume":"117","author":"Raymond","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"10-13","key":"jrv210017r51","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal.","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"issue":"2","key":"jrv210017r52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2004.10.007","article-title":"Cytochrome P450-mediated metabolism of estrogens and its regulation in human.","volume":"227","author":"Tsuchiya","year":"2005","journal-title":"Cancer Lett"},{"issue":"7","key":"jrv210017r54","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1097\/QAD.0000000000001392","article-title":"Drug interactions between hormonal contraceptives and antiretrovirals.","volume":"31","author":"Nanda","year":"2017","journal-title":"AIDS"},{"issue":"1","key":"jrv210017r55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy.","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"jrv210017r56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ajog.2017.07.003","article-title":"Drug interactions between non-rifamycin antibiotics and hormonal contraception: a systematic review.","volume":"218","author":"Simmons","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"jrv210017r57","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/bjo.2018.125.issue-7","article-title":"Drug interactions between rifamycin antibiotics and hormonal contraception: a systematic review.","volume":"125","author":"Simmons","year":"2018","journal-title":"BJOG"},{"issue":"3","key":"jrv210017r58","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/epi.2007.48.issue-3","article-title":"Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial.","volume":"48","author":"Christensen","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"jrv210017r59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/152.3.242","article-title":"Oral contraceptive and benign ovarian tumors.","volume":"152","author":"Westhoff","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"6586","key":"jrv210017r60","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1136\/bmj.294.6586.1518","article-title":"Ovarian neoplasms, functional ovarian cysts, and oral contraceptives.","volume":"294","author":"Vessey","year":"1987","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"7","key":"jrv210017r61","article-title":"Continuous or extended cycle vs cyclic use of combined hormonal contraceptives for contraception.","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"jrv210017r62","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub5","article-title":"Combined oral contraceptive pills for treatment of acne.","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"jrv210017r63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/bjd.2016.175.issue-1","article-title":"Interventions for hirsutism excluding laser and photoepilation therapy alone: abridged Cochrane systematic review including GRADE assessments.","volume":"175","author":"van Zuuren","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"jrv210017r64","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/aog.2004.83.issue-4","article-title":"Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: predictors of outcome.","volume":"83","author":"Hurskainen","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"jrv210017r65","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0015-0282(01)01909-4","article-title":"Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection.","volume":"76","author":"Istre","year":"2001","journal-title":"Fertil Steril"},{"key":"jrv210017r66","article-title":"Oral contraceptive pill for primary dysmenorrhoea.","author":"Wong","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"jrv210017r67","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.contraception.2012.09.025","article-title":"Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review.","volume":"87","author":"Lowe","year":"2013","journal-title":"Contraception"},{"key":"jrv210017r68","article-title":"Combined hormonal contraceptives for heavy menstrual bleeding.","volume":"2","author":"Lethaby","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"jrv210017r69","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/bjo.2005.112.issue-8","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.","volume":"112","author":"Reid","year":"2005","journal-title":"BJOG"},{"issue":"3","key":"jrv210017r70","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/AOG.0b013e3182839e0e","article-title":"Nonsurgical management of heavy menstrual bleeding: a systematic review.","volume":"121","author":"Matteson","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jrv210017r71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000080932","article-title":"The efficacy of levonorgestrel-releasing intrauterine device in selected cases of myoma-related menorrhagia: a prospective controlled trial.","volume":"59","author":"Soysal","year":"2005","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"jrv210017r72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.contraception.2003.11.008","article-title":"Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.","volume":"69","author":"Suhonen","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"jrv210017r73","article-title":"Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.","author":"Abou-Setta","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"jrv210017r74","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0015-0282(97)00245-8","article-title":"Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.","volume":"68","author":"Fedele","year":"1997","journal-title":"Fertil Steril"},{"issue":"2","key":"jrv210017r75","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00006250-199102000-00019","article-title":"Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years\u2019 comparative experience of levonorgestrel- and copper-releasing intrauterine devices.","volume":"77","author":"Toivonen","year":"1991","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jrv210017r76","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1783\/147118906775275370","article-title":"Does assessment of signs and symptoms add to the predictive value of an algorithm to rule out pregnancy?","volume":"32","author":"Stanback","year":"2006","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"2","key":"jrv210017r77","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/S1020-49892008000200007","article-title":"Validation of a job aid to rule out pregnancy among family planning clients in Nicaragua.","volume":"23","author":"Stanback","year":"2008","journal-title":"Rev Panam Salud Publica"},{"issue":"9178","key":"jrv210017r78","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(99)01578-0","article-title":"Checklist for ruling out pregnancy among family-planning clients in primary care.","volume":"354","author":"Stanback","year":"1999","journal-title":"Lancet"},{"issue":"14","key":"jrv210017r79","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1001\/jama.286.14.1759","article-title":"Natural limits of pregnancy testing in relation to the expected menstrual period.","volume":"286","author":"Wilcox","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"jrv210017r80","first-page":"391","article-title":"Human chorionic gonadotropin in maternal plasma after induced abortion, spontaneous abortion, and removed ectopic pregnancy.","volume":"64","author":"Steier","year":"1984","journal-title":"Obstet Gynecol"},{"issue":"5, pt 1","key":"jrv210017r81","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/01.AOG.0000142712.80407.fd","article-title":"Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve.","volume":"104","author":"Barnhart","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"3","key":"jrv210017r82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0010-7824(02)00351-7","article-title":"Quick Start: novel oral contraceptive initiation method.","volume":"66","author":"Westhoff","year":"2002","journal-title":"Contraception"},{"issue":"6","key":"jrv210017r83","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/01.AOG.0000264550.41242.f2","article-title":"Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial.","volume":"109","author":"Westhoff","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"5","key":"jrv210017r84","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.contraception.2005.11.003","article-title":"Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive.","volume":"73","author":"Schafer","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"jrv210017r85","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.contraception.2017.01.010","article-title":"Risk of luteal phase pregnancy with any-cycle-day initiation of subdermal contraceptive implants.","volume":"95","author":"Richards","year":"2017","journal-title":"Contraception"},{"issue":"4","key":"jrv210017r86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ije\/7.4.309","article-title":"Role of oral contraception in congenital malformations of offspring.","volume":"7","author":"Bracken","year":"1978","journal-title":"Int J Epidemiol"},{"issue":"3","key":"jrv210017r87","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/01.AOG.0000199950.64545.16","article-title":"Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?","volume":"107","author":"Edelman","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jrv210017r88","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003989.pub4","article-title":"20 \u00b5g versus >20 \u00b5g estrogen combined oral contraceptives for contraception.","author":"Gallo","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"jrv210017r89","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins.","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"3","key":"jrv210017r90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.contraception.2020.05.017","article-title":"Oral contraceptive generations: time to stop using a marketing myth to define nomenclature.","volume":"102","author":"Creinin","year":"2020","journal-title":"Contraception"},{"issue":"6","key":"jrv210017r91","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.contraception.2007.02.005","article-title":"Acceptability of contraceptive-induced amenorrhea in a racially diverse group of US women.","volume":"75","author":"Edelman","year":"2007","journal-title":"Contraception"},{"issue":"2","key":"jrv210017r92","first-page":"261","article-title":"Hormone withdrawal symptoms in oral contraceptive users.","volume":"95","author":"Sulak","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"1","key":"jrv210017r93","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0015-0282(16)58387-3","article-title":"Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.","volume":"66","author":"Ruchhoft","year":"1996","journal-title":"Fertil Steril"},{"issue":"3","key":"jrv210017r94","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs continuous oral contraceptive use.","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"jrv210017r95","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial.","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"jrv210017r96","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/AOG.0b013e31820095a2","article-title":"Effectiveness of oral contraceptive pills in a large US cohort comparing progestogen and regimen.","volume":"117","author":"Dinger","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"10","key":"jrv210017r97","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1080\/17512433.2019.1669448","article-title":"Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: a new year-long, patient controlled, reversible birth control method.","volume":"12","author":"Nelson","year":"2019","journal-title":"Expert Rev Clin Pharmacol"},{"key":"jrv210017r3","unstructured":"Centers for Disease Control and Prevention. National Ambulatory Medical Care survey: 2016 national summary tables. Accessed November 2, 2020. https:\/\/www.cdc.gov\/nchs\/data\/ahcd\/namcs_summary\/2016_namcs_web_tables.pdf"},{"key":"jrv210017r4","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. Key statistics from the National Survey of Family Growth\u2014S listing. Accessed September 17, 2021. https:\/\/www.cdc.gov\/nchs\/nsfg\/key_statistics\/s.htm"},{"key":"jrv210017r18","unstructured":"Contraceptive Technology. Table 26-1: percentage of women experiencing an unintended pregnancy during the first year of typical use and the first year of perfect use of contraception and the percentage continuing use at the end of the first year: United States. 2018. Accessed November 2, 2020. http:\/\/www.contraceptivetechnology.org\/wp-content\/uploads\/2013\/09\/Contraceptive-Failure-Rates.pdf"},{"key":"jrv210017r32","unstructured":"Centers for Disease Control and Prevention. United States Medical Eligibility Criteria for Contraceptive Use, 2016 (US MEC). Accessed October 29, 2020. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/mec\/summary.html"},{"key":"jrv210017r42","unstructured":"Centers for Disease Control and Prevention. US Selected Practice Recommendations for Contraceptive Use (US SPR). Accessed October 29, 2020. https:\/\/www.cdc.gov\/reproductivehealth\/contraception\/mmwr\/spr\/summary.html"},{"key":"jrv210017r53","unstructured":"Food and Drug Administration. Clinical drug interaction studies: Cytochrome P450 enzyme- and transporter-mediated drug interactions guidance for industry. Published January 2020. Accessed June 29, 2021. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2787541\/jama_teal_2021_rv_210017_1640292630.91562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T11:06:28Z","timestamp":1640689588000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2787541"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,12,28]]},"references-count":97,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2021,12,28]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.21392","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,28]]}}}